Medical Crossfire®: How Can We Refine Our Approaches to Better Personalize Patient Care in Community-Acquired Bacterial Pneumonia (CABP)?

Target Audience
This online educational activity is directed toward infectious disease specialists, hospitalists, emergency department physicians, primary care clinicians, pulmonologists, nurse practitioners, nurses, physician assistants, and other health care professionals interested in the treatment of CABP.

Activity Overview
The Medical Crossfire®, one of PER®’s signature educational formats, is a video-based program in which a panel of distinguished experts engage in spirted discussions and debates on a particular clinical topic. In this activity, a panel of 4 multidisciplinary experts explore the impact of community-acquired bacterial pneumonia (CABP) on specific patient populations, and share their approaches for diagnosis, including the use of clinical prediction tools. This lively discussion will help place new treatments that overcome drug-resistant pathogens into clinical context to help you optimize care for your patients with CABP.

Learning Objectives
Upon successful completion of this activity, you should be better prepared to:

Discuss the pathophysiology of drug resistance on the specific patient populations with community-acquired pneumonia (CAP)/CABP
Review the clinical impact and symptoms that patients with CAP/CABP may experience
Apply accepted criteria and recommendations in the early diagnosis and evaluation of patients with CABP and severe CABP
Evaluate the efficacy and safety data of current and developing therapies and therapy selection of antimicrobials for patients with CABP and severe CABP